INSULIN RESISTANCE OF ACANTHOSIS NIGRICANS
INSULIN RESISTANCE OF ACANTHOSIS NIGRICANS
批准号:
3232159
负责人:
CHARLES A STUART
金额:
$20.29万
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-12-01 至 1994-11-30
关键词:
acanthosis nigricans adipocytes androgens diabetes mellitus genetics epidemiology family female gene expression glucose tolerance test human subject hyperinsulinism insulin receptor insulin sensitivity /resistance longitudinal human study noninsulin dependent diabetes mellitus obesity ovary disorder point mutation tissue /cell culture
中文摘要
这项持续的研究项目旨在全面确定
导致胰岛素抵抗的具体机制
在以黑棘皮病皮肤为特征的常见人类综合征中,
损伤和显著内源性高胰岛素血症。 最常见的
这种情况的表现是在青春期的女性谁也有
肥胖和月经过少。 在青少年中,葡萄糖耐量
尽管有严重的胰岛素抵抗,但通常是正常的,但最近的数据表明,
代偿性胰岛素的逐渐丧失
分泌过多和最终发展为非胰岛素依赖性
糖尿病(NIDDM)。 进一步的数据表明,
增加了一些少数群体中皮肤病的发病率。 的
该项目的长期目标是(a)充分描述
对胰岛素的抵抗,(B)描述以下因素的相对重要性
这种综合征的遗传和获得因素,(c)确定
卵巢功能障碍及皮肤病变与胰岛素的关系
(d)确定哪种治疗可以有效地治疗
改善这种状况。 明年的短期目标是
测试以下假设。 (1)这些受试者中有许多患有严重
胰岛素抵抗具有一个或多个功能性内点突变
胰岛素受体的结构域。 为了验证这一假设,我们将确定
胰岛素受体基因有限部分的确切基因序列
对应于酪氨酸激酶结构域。 (2)黑棘皮病
皮肤病变,我们已经记录到有一个高患病率,
一般人群总是严重内源性
高胰岛素血症是胰岛素抵抗的补偿,
获得或继承。 这一假设将通过评估
胰岛素敏感性的每一个病人确定与黑棘皮病。
(3)这种胰岛素抵抗综合征有其自然的过程松散
胰腺β细胞储备并最终发展为明显的NIDDM。 这将
通过对所有确定的
患者,包括确定葡萄糖耐量和定量
胰岛素分泌和胰岛素反应性。 其他数据将
维持在肥胖、卵巢功能障碍、高血压、
和高脂血症。 (4)潜在胰岛素受体缺陷的评价
在每一个严重受影响的患者的父母将揭示一个或多个
特殊的结构异常 这一建议将由
评价胰岛素受体结构特性,胰岛素受体基因
表达和胰岛素受体基因结构在父母的12个
严重受影响的患者被确定具有特定的结构缺陷。
这些拟议的实验可能提供重要的洞察机制,
其他常见的健康问题,如肥胖,
和NIDDM。
英文摘要
This continuing research project is intended to comprehensively determine
the specific mechanisms which result in resistance to the action of insulin
in a common human syndrome characterized by the acanthosis nigricans skin
lesion and marked endogenous hyperinsulinemia. The most common
presentation of this condition is at puberty in females who also have
obesity and oligomenorrhea. In young adolescents, glucose tolerance is
often normal in spite of severe insulin resistance but recent data suggests
that there is frequently progressive loss of compensatory insulin
hypersecretion and the eventual development of non-insulin dependent
diabetes mellitus (NIDDM). Further data suggests this dramatically
increases incidence of the skin lesion among some minority groups. The
long term goals of this project are (a) to fully characterize the nature of
the resistance to insulin, (b) to delineate the relative importance of
genetic and acquired factors in this syndrome, (c) to determine the
relationship of the ovarian dysfunction and the skin lesions to the insulin
resistance, and (d) to determine what therapy can be effective in
ameliorating this condition. The short term goals in the next year are to
test the following hypotheses. (1) Many of these subjects with severe
insulin resistance have one or more point mutations within functional
domains of the insulin receptor. To test this hypothesis we will determine
the exact gene sequence of limited portions of insulin receptor gene
corresponding to the tyrosine kinase domains. (2) The acanthosis nigricans
skin lesion which we have documented to have a high prevalence in the
general population is always a marker for severe endogenous
hyperinsulinemia which is in compensation for insulin resistance, either
acquired or inherited. This hypothesis will be pursued by evaluating the
insulin sensitivity of every patient identified with acanthosis nigricans.
(3) This insulin resistance syndrome has as its natural course to loose
pancreatic beta cell reserve and eventually develop overt NIDDM. This will
be tested by performing yearly follow-up assessments in all identified
patients, consisting of determining glucose tolerance and quantitating
insulin secretion and insulin responsiveness. Additional data will be
maintained on the course of the obesity, ovarian dysfunction, hypertension,
and hyperlipidemia. (4) Evaluation of potential insulin receptor defects
in each parent of severely affected patients will reveal one or more
specific structural abnormalities. This suggestion will be tested by
evaluating insulin receptor structural properties, insulin receptor gene
expression, and insulin receptor gene structure in the parents of twelve
severely affected patients identified to have a specific structural defect.
These proposed experiments may provide important insight into mechanisms of
defective insulin action in other common health problems such as obesity
and NIDDM.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms by which strength training ameliorates the Metabolic Syndrome
-
批准号:8006750
-
项目类别:
-
资助金额:$0.67万
-
财政年份:2010
-
负责人:CHARLES A STUART
-
依托单位:
Mechanisms by which exercise training ameliorates the metabolic syndrome
-
批准号:8035605
-
项目类别:
-
资助金额:$38.72万
-
财政年份:2008
-
负责人:CHARLES A STUART
-
依托单位:
Mechanisms by which strength training ameliorates the Metabolic Syndrome
-
批准号:7522195
-
项目类别:
-
资助金额:$21.3万
-
财政年份:2008
-
负责人:CHARLES A STUART
-
依托单位:
INSULIN RESISTANCE, POLYCYSTIC OVARIAN DISEASE AND ACANTHOSIS NIGRICANS
-
批准号:6566702
-
项目类别:
-
资助金额:$27.93万
-
财政年份:2001
-
负责人:CHARLES A STUART
-
依托单位:
INSULIN RESISTANCE, POLYCYSTIC OVARIAN DISEASE AND ACANTHOSIS NIGRICANS
-
批准号:6413641
-
项目类别:
-
资助金额:$27.93万
-
财政年份:2000
-
负责人:CHARLES A STUART
-
依托单位:
INSULIN RESISTANCE, POLYCYSTIC OVARIAN DISEASE AND ACANTHOSIS NIGRICANS
-
批准号:6305262
-
项目类别:
-
资助金额:$3.42万
-
财政年份:1999
-
负责人:CHARLES A STUART
-
依托单位:
DISUSE MUSCLE ATROPHY--MECHANISM OF DEVELOPMENT
-
批准号:6115159
-
项目类别:
-
资助金额:$3.42万
-
财政年份:1998
-
负责人:CHARLES A STUART
-
依托单位:
ALPHA2 ADRENERGIC RECEPTOR DYSFUNCTION IN PATIENTS W/ REGIONAL LIPOAT
-
批准号:6264367
-
项目类别:
-
资助金额:$3.42万
-
财政年份:1998
-
负责人:CHARLES A STUART
-
依托单位:
INSULIN RESISTANCE, POLYCYSTIC OVARIAN DISEASE AND ACANTHOSIS NIGRICANS
-
批准号:6115141
-
项目类别:
-
资助金额:$3.42万
-
财政年份:1998
-
负责人:CHARLES A STUART
-
依托单位:
DISUSE MUSCLE ATROPHY--MECHANISM OF DEVELOPMENT
-
批准号:6276394
-
项目类别:
-
资助金额:$2.69万
-
财政年份:1997
-
负责人:CHARLES A STUART
-
依托单位:
DISUSE MUSCLE ATROPHY--MECHANISM OF DEVELOPMENT
-
批准号:6246314
-
项目类别:
-
资助金额:$2.71万
-
财政年份:1997
-
负责人:CHARLES A STUART
-
依托单位:
INSULIN RESISTANCE, POLYCYSTIC OVARIAN DISEASE AND ACANTHOSIS NIGRICANS
-
批准号:6246288
-
项目类别:
-
资助金额:$2.71万
-
财政年份:1997
-
负责人:CHARLES A STUART
-
依托单位:
ALPHA2 ADRENERGIC RECEPTOR DYSFUNCTION IN PATIENTS WITH REGIONAL LIPOATROPHY
-
批准号:6246342
-
项目类别:
-
资助金额:$2.71万
-
财政年份:1997
-
负责人:CHARLES A STUART
-
依托单位:
INSULIN RESISTANCE, POLYCYSTIC OVARIAN DISEASE AND ACANTHOSIS NIGRICANS
-
批准号:6276376
-
项目类别:
-
资助金额:$2.69万
-
财政年份:1997
-
负责人:CHARLES A STUART
-
依托单位:
CLINICAL RESEARCH CENTER VOLUNTEER DATABASE
-
批准号:6246318
-
项目类别:
-
资助金额:$2.71万
-
财政年份:1997
-
负责人:CHARLES A STUART
-
依托单位:
DIABETES PREVENTION IN NORTHERN PLAINS INDIAN CHILDREN
-
批准号:2462400
-
项目类别:
-
资助金额:$12.1万
-
财政年份:1993
-
负责人:CHARLES A STUART
-
依托单位:
DIABETES PREVENTION IN NORTHERN PLAINS INDIAN CHILDREN
-
批准号:2016716
-
项目类别:
-
资助金额:$7.2万
-
财政年份:1993
-
负责人:CHARLES A STUART
-
依托单位:
THE INSULIN RESISTANCE OF ACANTHOSIS NIGRICANS
-
批准号:3232158
-
项目类别:
-
资助金额:$18.94万
-
财政年份:1984
-
负责人:CHARLES A STUART
-
依托单位:
THE INSULIN RESISTANCE OF ACANTHOSIS NIGRICANS
-
批准号:3232160
-
项目类别:
-
资助金额:$21.49万
-
财政年份:1984
-
负责人:CHARLES A STUART
-
依托单位:
THE INSULIN RESISTANCE OF ACANTHOSIS NIGRICANS
-
批准号:3152929
-
项目类别:
-
资助金额:$8.47万
-
财政年份:1984
-
负责人:CHARLES A STUART
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: